MYD88 and acute respiratory distress syndrome: Additionally, Zhu W et al. showed that Schisandrin B (Sch B) directly targets MyD88, inhibiting key inflammatory pathways, reducing inflammatory cytokine production, and preventing oxidative stress, highlighting its therapeutic potential for ALI [23].